Sign InOpen an account

Autolus Therapeutics Plc ADR

Buy-Sell-
Available to platforms
R StocksTrader
Autolus Therapeutics Plc (AUTL) is a clinical-stage biopharmaceutical company focused on developing next-generation, programmed T-cell therapies for the treatment of cancer. Headquartered in London, United Kingdom, Autolus leverages its proprietary technology platforms to engineer precision CAR-T (Chimeric Antigen Receptor T-cell) therapies aimed at delivering transformative outcomes for patients with hematological malignancies and solid tumors. The company’s innovative approach combines advanced cell programming with sophisticated manufacturing processes to create highly specific and durable treatments. Autolus is dedicated to addressing unmet medical needs and advancing the field of cell and gene therapy.

Autolus Therapeutics Plc ADR (AUTL) on the NASDAQ Exchange

Company overview

Autolus Therapeutics Plc ADR is a publicly listed company from USA with shares traded on NASDAQ under the ticker AUTL. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for AUTL are bid 1.26 USD and ask 1.3 USD.

Use the chart to review recent momentum, identify key price areas, and track how Autolus Therapeutics Plc ADR is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add AUTL to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.

Key facts

  • Exchange: NASDAQ
  • Company: Autolus Therapeutics Plc ADR
  • Ticker: AUTL
  • Country: USA
  • Bid:  1.26 USD
  • Ask:  1.3 USD
  • Quotes: real-time, auto-updated

Risk

Risk Warning: Past performance of AUTL does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for Autolus Therapeutics Plc ADR (AUTL) in R StocksTrader. Create and verify your profile, fund the account, search for AUTL, and choose the instrument type available to you. Add AUTL to your Watchlist to track moves and manage open positions throughout 2025.

AUTL trades on NASDAQ and is issued by Autolus Therapeutics Plc ADR. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for AUTL match your plan.

Quotes update automatically in real time. Current levels for AUTL are bid 1.26 USD and ask 1.3 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track AUTL in R StocksTrader and adjust your approach as market conditions change in 2025.

All financial charts